Author: Choi, Kang-Seuk
Title: Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines Document date: 2017_7_26
ID: vk59ghjm_18
Snippet: NDV-vectored vaccines may be useful against human influenza viruses. Nakaya et al. [35] developed a NDV-vectored human influenza vaccine (rNDV/B1-HA) expressing the HA protein of A/WSN/33 influenza virus (H1N1). Two intravenous inoculations of mice with the rNDV/B1-HA vaccine (3×10 7 PFU/dose) induced a strong anti-influenza virus antibody response and provided complete protection against lethal challenge with influenza A/WSN/33 virus. Recently,.....
Document: NDV-vectored vaccines may be useful against human influenza viruses. Nakaya et al. [35] developed a NDV-vectored human influenza vaccine (rNDV/B1-HA) expressing the HA protein of A/WSN/33 influenza virus (H1N1). Two intravenous inoculations of mice with the rNDV/B1-HA vaccine (3×10 7 PFU/dose) induced a strong anti-influenza virus antibody response and provided complete protection against lethal challenge with influenza A/WSN/33 virus. Recently, DiNapoli et al. [36] developed a NDV-vectored HPAIV vaccine (NDV-HA) expressing the HA protein of A/Vietnam/1203/04(H5N1) HPAIV for use in humans. Its protective efficacy against HPAIV was evaluated in an African green monkey model. Two oro-nasal administrations of NDV-HA (2×10 7 PFU/dose) induced a high serum titer of HPAIV neutralizing antibodies and a robust mucosal immunoglobulin A response in the respiratory tract. These results suggest that NDV-HA may be an effective human vaccine for HPAIV.
Search related documents:
Co phrase search for related documents- african green monkey model and green monkey model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- anti influenza virus and H1N1 influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- anti influenza virus and HA protein: 1, 2, 3, 4
- anti influenza virus and HA protein express: 1
- anti influenza virus and human influenza: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- anti influenza virus and human influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- anti influenza virus and influenza lethal challenge: 1, 2
- anti influenza virus and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- anti influenza virus and lethal challenge: 1, 2, 3
- anti influenza virus and protective efficacy: 1
- anti influenza virus and respiratory tract: 1, 2, 3, 4, 5, 6
- antibody response and complete protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antibody response and H1N1 influenza virus: 1, 2, 3, 4, 5, 6, 7, 8
- antibody response and HA protein: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antibody response and high serum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- antibody response and high serum titer: 1, 2
- antibody response and human influenza: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- antibody response and human influenza vaccine: 1, 2
Co phrase search for related documents, hyperlinks ordered by date